Data presented at the world pain congress show Pain Therapeutic/Kings oxycodoen product REMOXY to provide effective around-the-clock analgesia
Filed under: gpcr | Tagged: EpiLeukin, oxycodone, Pain Therapeutics, REMOXY | Leave a Comment »
Tags
5-HT1A 5-HT2 5-HT2A 5-HT3 5-HT4 5-ht6 5HT1A 5HT1D 5HT2 5HT2A 5HT3 5HT4 5ht6 agonist Angiotensin II AT1 antagonist Astrazeneca Beta 2 adrenoceptor Cannabinoid CB1 Daiichi-Sankyo Dopamine Dopamine D2 Fentanyl ghrelin GlaxoSmithkline GLP-1 gpcr GSK Histamine H1 Licensing Lilly Merck Muscarinic Opioid Opioid mu phase I phase II phase III Preclinical regulatory Research Sanofi-Aventis TRPV1 Vanilloid
Calendar
Blogroll
Blog at WordPress.com. Theme: Digg 3 Column by WP Designer
